Evaluation of pediatric patients with hepatitis A.

INTRODUCTION Hepatitis A is the most common form of acute viral hepatitis worldwide, especially in children. The clinical severity of the hepatitis A virus (HAV) infection varies from an asymptomatic infection to a fulminant disease. In this study, we aimed to evaluate characteristics of pediatric patients diagnosed with HAV infection. METHODOLOGY Patients younger than 18 years of age admitted between January 1, 2006 and January 1, 2011 to our hospital, an important reference center located in the middle part of Turkey, diagnosed as having hepatitis A were evaluated. RESULTS Of 427 patients, 49.4% were female and 50.6% were male. Hospitalization rate of the patients was 28.3%. The reason for hospitalization was vomitting in 58.7% of the patients and abdominal pain in 28%. The mean time of hospitalization was 5.2 ± 4.5 (1-40) days. There was no significant difference in hospitalization time by age. Vomiting and abdominal pain were significantly more common, and PT and aPTT levels were significantly elevated in patients with elevated AST and ALT levels over 1000 IU/L (p < 0.001). PT elevation was present in 15.2% of the patients, aPTT elevation in 11.9%, leukopenia in 16.6%, and thrombocytopenia in 2.6%. In terms of atypical course, four patients (0.9%) had cholestatic hepatitis, one had recurrent hepatitis, and one had fulminant hepatitis, yet no mortality was observed. CONCLUSIONS Atypical courses of hepatitis A were more scarce in pediatric patients, but careful follow-up of patients with AST and ALT levels > 1000 IU/L is necessary.

[1]  M. Campagna,et al.  Changing Pattern of Hepatitis A Virus Epidemiology in an Area of High Endemicity , 2012, Hepatitis monthly.

[2]  L. Serino,et al.  Hepatitis A: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[3]  M. Choi,et al.  [Clinical features and predictive factors of acute hepatitis A complicated with acute kidney injury]. , 2010, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[4]  K. Jacobsen,et al.  Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. , 2010, Vaccine.

[5]  P. van Damme,et al.  Hepatitis A and E: update on prevention and epidemiology. , 2010, Vaccine.

[6]  Hyo‐suk Lee,et al.  Hepatitis A: Clinical Manifestations and Management , 2010, Intervirology.

[7]  R. Jiménez-García,et al.  Trends of hepatitis A hospitalizations and costs associated with the hospitalization in Spain (2000–2005) , 2009, Journal of viral hepatitis.

[8]  M. Hacımustafaoğlu,et al.  Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations , 2008, Journal of viral hepatitis.

[9]  A. Monto,et al.  Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. , 2006, American journal of epidemiology.

[10]  G. Kanra,et al.  Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. , 2002, The Turkish journal of pediatrics.

[11]  M. Ciocca Clinical course and consequences of hepatitis A infection. , 2000, Vaccine.

[12]  Z. Bittar Hepatitis A vaccines. , 1996, Le Journal medical libanais. The Lebanese medical journal.

[13]  M. CarmenMaroto,et al.  Hepatitis A virus , 1995 .

[14]  K. Cann Principles and practice of infectious disease , 1990 .

[15]  D. Wilton,et al.  [Hepatitis A]. , 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[17]  B. Bell,et al.  Hepatitis A virus , 2016 .